Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

Obesity is classified as a chronic disease that needs medical ... said she had struggled to lose weight for years because of ...

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...

Katie Price has revealed her 22-year-old son Harvey is to begin Ozempic-style weight-loss injections in a bid to save his ...